FluxMPS™ Dulbecco's Modified Eagle Medium (DMEM), Low Glucose Family

About DMEM, Low Glucose

Dulbecco's Modified Eagle Medium (DMEM) is one of the most widely used modifications of Eagle's medium. DMEM is a modification of Basal Medium Eagle (BME) that contains four-fold concentrations of amino acids and vitamins. The formulation also includes glycine, serine, and ferric nitrate. The original formulation contained 1000 mg/L glucose and was originally used to culture embryonic mouse cells.

This Low Glucose family preserves the original 1.0 g/L (5.55 mM) glucose concentration, which is suitable for growing cells that may be adversely affected by high glucose concentrations, such as certain primary cells, stem cells, or transformed cell lines.

Origins and Development

DMEM traces directly to Harry Eagle's foundational work at the National Institutes of Health, where his 1955 studies defined the minimal nutritional requirements of HeLa and L (L929) cells and led to the development of Basal Medium Eagle later noted that BME emerged from systematic nutritional studies rather than from a planned attempt to design a culture medium. In 1959, Eagle expanded BME into Minimum Essential Medium (MEM) by increasing amino acid concentrations to extend culture maintenance and broaden the range of supported cell lines.

That same year, Renato Dulbecco and G. Freeman introduced their own modification of Eagle's medium in a footnote in their Virology paper on plaque production by the polyoma virus (Virology 8: 396–397, 1959). The modification — now universally known as Dulbecco's Modified Eagle Medium (DMEM, or DME) — had substantially higher concentrations of amino acids and vitamins than BME and was used to support the culture of mouse embryonic cells in monolayers needed for quantitative virus plaque assays. As with Eagle's original work, the medium emerged as a practical tool in service of a virological objective rather than as a standalone engineering goal, and it likewise depended on serum supplementation to support proliferation.

In the decade that followed, the formulation was adapted and commercialized in several variants. Higher-glucose versions (4.5 g/L) were developed to support rapidly proliferating and transformed cell lines, and DMEM was extended to primary cultures of mouse and chicken cells, as well as a broad spectrum of normal and transformed cell types. Surveys of commercial media from this period (Morton, 1970) document how DMEM diversified into the family of glucose-, pyruvate-, glutamine-, and buffer-variant media still in use today.

Note on parent formulation: Multiple authoritative sources — including the Cantor 2019 Trends in Cell Biology review, Sigma-Aldrich, and Corning — classify DMEM as a derivative of BME. Some commercial literature describes the four-fold enrichment relative to "Eagle's Minimal Essential Medium"; the Dulbecco footnote itself refers simply to "Eagle's medium." The scientific consensus, anchored by primary review literature, identifies BME as the direct parent.

The DMEM Family Tree

DMEM sits in the middle of a lineage that begins with Eagle and continues into several enriched descendants:

• BME (1955, Eagle) — the parent formulation; a basal amino acid and vitamin mix, including glutamine, biotin, and baseline inorganic salts.
• MEM (1959, Eagle) — a BME derivative with increased amino acid concentrations; biotin was omitted after Eagle found it dispensable.
• DMEM (1959, Dulbecco & Freeman) — a further-enriched BME modification (approximately 4x amino acids and vitamins vs. BME) with 15 amino acids (adding glycine and L-serine to the Eagle essential set) and added ferric nitrate, originally for mouse embryonic cells and viral plaque assays.
• DMEM/F-12 — a 1:1 mixture of high-glucose DMEM and Ham's F-12, combining DMEM's rich amino acid/vitamin profile with F-12's trace elements and lipids for lower-serum and serum-free work.
• IMDM (Iscove's Modified Dulbecco's Medium, 1978; Iscove & Melchers) — an enriched DMEM derivative adding selenium, additional amino acids and vitamins, sodium pyruvate, HEPES buffer, and potassium nitrate in place of ferric nitrate; designed for high-density, rapidly proliferating cultures such as lymphocytes and hematopoietic cells.

In parallel, the broader Eagle lineage also gave rise to RPMI 1640, developed by Moore, Gerner, and Franklin at Roswell Park Memorial Institute (1966; published in JAMA 199: 519-524, 1967). RPMI 1640's direct parent is McCoy's 5A Modified Medium, which was itself based in part on BME — illustrating how a single nutritional framework branched into the modern catalog of classical media.